880670 | C8 PEG750 Ceramide
N-octanoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)750]}

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
C8 PEG750 Ceramide
N-octanoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)750]}
Representative Structure
The formula weight and exact mass are averages based on the polydispersity of PEG.
C63H121NO22 (average FW due to polydispersity of PEG)
C 60.80%, H 9.80%, N 1.13%, O 28.28%
CAS Registry Number is a Registered Trademark of the American Chemical Society
Lv H, Zhang Z, Wu X, Wang Y, Li C, Gong W, Gui L, Wang X. Preclinical Evaluation of Liposomal C8 Ceramide as a Potent anti-Hepatocellular Carcinoma Agent. PLoS One. 2016 Jan 4;11(1):e0145195. doi: 10.1371/journal.pone.0145195. PMID: 26727592; PMCID: PMC4699687.
PubMed ID: 26727592- Certificate of Analysis (Lot No. 880670P-25MG-A-016 and 6336PJA016)
- Certificate of Analysis (Lot No. 880670P-25MG-C-016 and 6336PJC016)